Macquarie Group
ARVN icon

Macquarie Group’s Arvinas ARVN Stock Holding History

Macquarie Group’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-180,000
Closed -$1.53M – 898
2025
Q3 		$1.53M Hold
180,000
– – ﹤0.01% 1246
2025
Q2 		$1.32M Hold
180,000
– – ﹤0.01% 1322
2025
Q1 		$1.26M Buy
+180,000
New +$2.82M ﹤0.01% 1350
2022
Q4 		– Sell
-1,170
Closed -$92K – 1772
2022
Q3 		$92K Sell
1,170
-281
-19% -$13.6K ﹤0.01% 1788
2022
Q2 		$61K Hold
1,451
– – ﹤0.01% 1998
2022
Q1 		$98K Sell
1,451
-258
-15% -$17.6K ﹤0.01% 1955
2021
Q4 		$140K Buy
1,709
+284
+20% +$23.1K ﹤0.01% 1845
2021
Q3 		$117K Hold
1,425
– – ﹤0.01% 1936
2021
Q2 		$110K Buy
1,425
+821
+136% +$57K ﹤0.01% 1945
2021
Q1 		$40K Sell
604
-286
-32% -$21.9K ﹤0.01% 2126
2020
Q4 		$76K Buy
890
+573
+181% +$19.8K ﹤0.01% 1935
2020
Q3 		$7K Hold
317
– – ﹤0.01% 2311
2020
Q2 		$11K Buy
+317
New +$13.5K ﹤0.01% 2273

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Macquarie Group's ARVN Position: Q4 2025 in Review

Macquarie Group sold out of Arvinas (ARVN) in Q4 2025, closing a stake of 180,000 shares — an estimated $1.53M sold.

Macquarie Group first reported a position in ARVN in Q2 2020 and held it in 13 quarters. The position peaked at $1.53M in Q3 2025. 206 funds tracked by Wall St. Rank hold ARVN as of Q4 2025.

  • Macquarie Group reported no remaining Arvinas position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 180,000 Arvinas shares in Q4 2025, an estimated $1.53M.
  • Macquarie Group first reported a position in Arvinas in Q2 2020 and held it in 13 quarters.
  • Macquarie Group's Arvinas position peaked at $1.53M in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Arvinas as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.